NCT01653093View on ClinicalTrials.gov

3-Tesla MRI in Finding Tumors in Patients With Known or Suspected Prostate Cancer

NAActive, not recruitingINTERVENTIONAL
Enrollment

280

Participants

Timeline

Start Date

September 20, 2007

Primary Completion Date

December 31, 2026

Study Completion Date

December 31, 2026

Conditions
Prostate Cancer
Interventions
PROCEDURE

3-Tesla magnetic resonance imaging (3T MRI)

Undergo 3T MRI

PROCEDURE

diffusion-weighted magnetic resonance imaging

Undergo diffusion-weighted MRI

PROCEDURE

dynamic contrast-enhanced magnetic resonance imaging

Undergo DCE-MRI

PROCEDURE

magnetic resonance spectroscopic imaging

Undergo MR spectroscopy

Trial Locations (1)

43210

The Ohio State University Medical Center, Stress, Columbus

All Listed Sponsors
lead

University of Cincinnati

OTHER